ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

BRENDA BLOHM MD

2817 NEW PINERY RD DIVINE SAVIOR HEALTHCARE INC

Portage | Wisconsin | 53901

(608) 745-4598

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,207Medicare Part D Prescriptions Filled, Including Refills

Rank: 226 out of 1802

$390K Total Retail Price of All Prescriptions

Rank: 204 out of 1802

234 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 234 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 234 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 5,377 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
OMEPRAZOLE 309 244 1 4
FUROSEMIDE 246 185 2 5
GABAPENTIN 239 164 3 16
HYDROCODONE-ACETAMINOPHEN 209 127 S3 4 10
METOPROLOL TARTRATE 188 152 5 9
AMLODIPINE BESYLATE 180 172 6 6
POTASSIUM CHLORIDE 172 139 7 15
WARFARIN SODIUM 155 126 8 7
ATENOLOL 152 105 9 12
METFORMIN HCL 149 135 10 11
HYDROCHLOROTHIAZIDE 149 128 10 8
LISINOPRIL 147 142 12 3
LEVOTHYROXINE SODIUM 145 121 13 2
SIMVASTATIN 120 101 14 1
OXYCODONE HCL 99 48 S2 15 41
FENTANYL 87 64 S2 16 43
MIRTAZAPINE 85 75 17 38
OXYBUTYNIN CHLORIDE 82 60 18 87
CARVEDILOL 79 79 19 36
LANTUS SOLOSTAR 79 52 19 63
TRAMADOL HCL 76 55 21 22
ALLOPURINOL 75 75 22 24
METOPROLOL SUCCINATE 73 63 23 13
KLOR-CON 10 71 52 24 117
FLUOXETINE HCL 71 39 24 35
ALENDRONATE SODIUM 71 46 24 21
MORPHINE SULFATE ER 70 40 S2 27 71
DIOVAN 69 56 28 57
TRAZODONE HCL 64 50 29 39
PREDNISONE 60 42 30 33
ADVAIR DISKUS 57 55 31 32
PEN NEEDLE 57 34 31 124
RANITIDINE HCL 54 30 33 30
LOSARTAN POTASSIUM 52 41 34 18
RISPERIDONE 50 37 35 64
CITALOPRAM HBR 50 47 35 17
CYMBALTA 50 17 35 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.